文献速递肝胆胰外科胃肠外科

腹腔镜与开腹切除治疗结直肠癌肝转移:OSLO-COMET随机对照试验

Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial.
PubMed 文献 · Ann Surg · 2018-01-01

OSLO-COMET是首个比较腹腔镜与开腹肝切除的随机对照试验,纳入挪威奥斯陆大学医院280例可切除结直肠癌肝转移患者,随机分为腹腔镜组133例与开腹组147例,行保留肝实质的肝切除。主要结局为术后30天内并发症(Accordion 2级及以上)。结果显示腹腔镜组并发症率19%,开腹组31%,差异有统计学意义;腹腔镜组术后住院更短,两组在失血量、手术时间和切缘方面没有差异。

要点

  • 腹腔镜组术后30天并发症率19%,低于开腹组的31%,差异为12个百分点。
  • 腹腔镜组术后住院53小时,短于开腹组的96小时。
  • 两组失血量、手术时间和切缘无差异,结果支持继续开展腹腔镜肝切除。

核心结论

  • 在结直肠癌肝转移行保留肝实质肝切除的患者中,腹腔镜手术相比开腹手术与更少的术后并发症相关。
  • 腹腔镜切除相比开腹切除具有成本效益,概率为67%。
  • 两组的切缘阴性率相同,结果支持继续实施腹腔镜肝切除。

研究设计与样本

  • 解释性、评估者盲法、单中心、随机优效性试验,招募时间为2012年2月至2016年1月,地点为挪威奥斯陆大学医院。
  • 共280例可切除结直肠癌肝转移患者,随机分为腹腔镜组133例与开腹组147例,均行保留肝实质的肝切除。
  • 主要结局为术后30天内并发症(Accordion 2级及以上)。

主要发现

  • 术后并发症率腹腔镜组19%,开腹组31%,差异12个百分点(95%CI 1.67-21.8;P=0.021)。
  • 术后住院时间腹腔镜组53小时,开腹组96小时(P<0.001)。
  • 失血量、手术时间和切缘在两组间无差异。
  • 90天死亡率腹腔镜组0例,开腹组1例,两组差异无统计学意义。
  • 在4个月观察期内,两组费用相等,腹腔镜组比开腹组多获得0.011质量调整生命年(P=0.001)。

关键数值与推荐

  • 主要结局为术后30天内Accordion 2级及以上并发症。
  • 并发症率差异为12个百分点(95%CI 1.67-21.8;P=0.021)。
  • 术后住院53小时比96小时(P<0.001)。
  • 成本效益概率67%;质量调整生命年增益0.011(P=0.001)。

临床怎么用

  • 对可切除结直肠癌肝转移行保留肝实质肝切除时,可优先考虑腹腔镜入路以降低术后并发症并缩短住院。
  • 腹腔镜与开腹在失血量、手术时间和切缘方面无差异,切缘安全性相当。
  • 在4个月观察期内,腹腔镜组的费用与开腹组相当,并且质量调整生命年略有增益。

局限性

  • 单中心研究,外推需谨慎。
  • 为解释性、评估者盲法设计,非双盲。
  • 主要结局限于术后30天内Accordion 2级及以上并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To perform the first randomized controlled trial to compare laparoscopic and open liver resection. SUMMARY BACKGROUND DATA: Laparoscopic liver resection is increasingly used for the surgical treatment of liver tumors. However, high-level evidence to conclude that laparoscopic liver resection is superior to open liver resection is lacking. METHODS: Explanatory, assessor-blinded, single center, randomized superiority trial recruiting patients from Oslo University Hospital, Oslo, Norway from February 2012 to January 2016. A total of 280 patients with resectable liver metastases from colorectal cancer were randomly assigned to undergo laparoscopic (n = 133) or open (n = 147) parenchyma-sparing liver resection. The primary outcome was postoperative complications within 30 days (Accordion grade 2 or higher). Secondary outcomes included cost-effectiveness, postoperative hospital stay, blood loss, operation time, and resection margins. RESULTS: The postoperative complication rate was 19% in the laparoscopic-surgery group and 31% in the open-surgery group (12 percentage points difference [95% confidence interval 1.67-21.8; P = 0.021]). The postoperative hospital stay was shorter for laparoscopic surgery (53 vs 96 hours, P < 0.001), whereas there were no differences in blood loss, operation time, and resection margins. Mortality at 90 days did not differ significantly from the laparoscopic group (0 patients) to the open group (1 patient). In a 4-month perspective, the costs were equal, whereas patients in the laparoscopic-surgery group gained 0.011 quality-adjusted life years compared to patients in the open-surgery group (P = 0.001). CONCLUSIONS: In patients undergoing parenchyma-sparing liver resection for colorectal metastases, laparoscopic surgery was associated with significantly less postoperative complications compared to open surgery. Laparoscopic resection was cost-effective compared to open resection with a 67% probability. The rate of free resection margins was the same in both groups. Our results support the continued implementation of laparoscopic liver resection.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, et al. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg. 2018. PMID: 28657937. doi:10.1097/SLA.0000000000002353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。